Thomas C. Krivak

No ORCID on file · 3 papers in corpus
2013
Endometriosis-derived clear-cell carcinoma masquerading as vaginal cancer
·doi:10.37549/aro1031
other 2012
Differential analysis of ovarian and endometrial cancers identifies a methylator phenotype
PloS one ·doi:10.1371/journal.pone.0032941

Despite improved outcomes in the past 30 years, less than half of all women diagnosed with epithelial ovarian cancer live five years beyond their diagnosis. Although typically treated as a single disease, epithelial ovarian cancer includes …

rct 2009
A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: an analysis of patients enrolled in GOG 172
Gynecologic Oncology ·doi:10.1016/j.ygyno.2009.06.021

OBJECTIVE: Serum CA-125 values have been advocated in the monitoring of ovarian cancer patients receiving intravenous (IV) chemotherapy. This evaluation sought to determine if the CA-125 test can be used to monitor treatment effect among pa…